New injection recommendations for patients with diabetes. Diabetes Metab 2010: 36 (Suppl. 2): S3-S18.Frid A, Hirsch L, Gaspar G, et al.: New injection recom- mendations for patients with diabetes. Diabetes Metab 2010; 36(Suppl 2):S3-S18....
“Glucagon-like peptide-1 agonist (GLP-1) drugs have transformed type 2 diabetes care, but weekly injections can be burdensome for patients. A single shot a month could make it much easier for people living with diabetes or obesity to stick to their drug regimens, improving quality of li...
FDA approves tirzepatide: A potent new drug for type 2 diabetes 图片上传失败 重试 The Food and Drug Administration (FDA) has approved a novel first-in-class drug to treat type 2 diabetes. The drug is called tirzepatide. A person has it as a once-weekly injection under the skin. I...
Medications for diabetes comprise either GLP-1 receptor agonists, with short (one or two daily injections: Exenatide, Liraglutide, Lixisenatide) or long duration (one injection once weekly: extended-released Exenatide, Albiglutide, Dulaglutide, Taspoglutide); or oral compounds inhibiting dipeptidyl peptid...
injection frequency compared to currently available drugs. Clinical trials comparing the efficacy of once-weekly somatrogon with once-daily analogue of the somatotropin hormone somatropin have demonstrated similar effects on height velocity along with comparable safety and tolerability profiles for both ...
For example, cardiovascular disease (CVD) is diagnosed in more than 30% of individuals with type 2 diabetes (T2D) [3, 4]. Similarly, at least 40% of people with T2D develop diabetic kidney disease (DKD), which is a major cause of chronic kidney disease (CKD) [5, 6]. Besides cancer...
Another study has shown that mean pulmonary artery pressure (mPAP) and mean right ventricle pressure (mRVP) were reduced significantly in pul- monary arterial hypertensive rats who received intravenous injection of MSC-derived MVs or MSCs[94]. More recently, it has been shown that in diabetes ...
multiple administration on a once-weekly (QW) or bi-weekly (Q2W) dosing interval. A total of 36 obese participants were enrolled in the study and randomized in a 3:1 ratio to receive a dose titration of 1.5 mg to 30 mg of GZR18 Injection or a matching placebo for a total of 35 ...
The guidelines come as new drug treatments for obesity in kids have emerged, including approval late last month of Wegovy, a weekly injection, for use in children ages 12 and older. Different doses of the drug, called semaglutide, are also used under different names to treat diabetes. A rec...
Perhaps unsurprisingly, Wegovy — a weekly injection patients self-administer using a small device that looks a bit like an EpiPen — has plenty of fans. Patients like Robillard, for one. While her day job is still working for a union, she now works part-time as a Novo Nordisk spokesperso...